Correlation Between Syndax Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Syndax Pharmaceuticals and Blueprint Medicines
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Syndax and Blueprint is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to under-perform the Blueprint Medicines. In addition to that, Syndax Pharmaceuticals is 1.64 times more volatile than Blueprint Medicines Corp. It trades about -0.05 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.04 per unit of volatility. If you would invest 9,253 in Blueprint Medicines Corp on September 3, 2024 and sell it today you would earn a total of 385.00 from holding Blueprint Medicines Corp or generate 4.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Blueprint Medicines Corp |
Syndax Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Syndax Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |